Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
ConclusionsWe revealed a robust link between cancer stemness and immunotherapy resistance and developed a promising signature, Stem.Sig, which showed increased performance in comparison to other signatures regarding ICI response prediction. This signature could serve as a competitive tool for patient selection of immunotherapy. Meanwhile, our study potentially paves the way for overcoming immune resistance by targeting stemness-associated genes.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research
More News: Basal Cell Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Genetics | Immunotherapy | Learning | Melanoma | Skin Cancer | Study | Universities & Medical Training